Bookmark and Share

 

LITIGATION

» Access to Courts and Court Remedies

» Campaign Finance and Election Laws

» Constitutional Rights and Requirements

» Health, Safety, and Environment

» Open Government and Open Courts

» Representing Consumers

» Workers' Rights


Currently Featured Topics

Government Transparency
Consumer Justice
First Amendment
Health, Safety and the Environment

SUPREME COURT
ASSISTANCE PROJECT

Read about our work helping lawyers
with cases in the Supreme Court.

 


Public Citizen | Drug Industry: Prices, Profits & Campaign Contributions - Drug Industry: Prices, Profits, R&D, Campaign Contributions & Lobbying

Drug Industry:
Prices, Profits and R&D,
Campaign Contributions & Lobbying

  • Prescription Drug Prices

(11/7/02) Public Citizen's Post-Election Analysis: Handful of Senate Moderates Now Hold Key to Protecting Consumer Interests

(6/20/01) Washington Post: Prescription for Profit

(4/10/00) HHS Report Confirms Existence of Prescription Drug Price Discrimination

Full Text of the Health and Human Services Report to the President: Prescription Drug Coverage, Spending, Utilization and Prices

(1/26/00) Methods Used by European Countries To Obtain Reasonable Drug Prices for Consumers

Information on the Allen Bill: Prescription Drug Fairness for Seniors Act

Statement on International Drug Parity Act of 1999 (H.R. 1885/S. 1191)

  • Corporate Profits and Drug Industry R&D

(6/23/03) 2002 Drug Industry Profits: Hefty Pharmaceutical Company Margins Dwarf Other Industries

(6/26/02) Would Lower Prescription Drug Prices Curb Drug Company Research & Development?

(4/18/02) Pharmaceutical Industry Ranks as Most Profitable Industry, Again (Press Release)

(4/16/02) Pharmaceuticals Rank as Most Profitable Industry, Again

(12/4/01) Tufts Drug Study Sample Is Skewed; True Figure of R&D Costs Likely Is 75 Percent Lower

(12/4/01) Critique of the DiMasi/Tufts Methodology and Other Key Prescription Drug R&D Issues

(11/28/01) Rebuttals to PhRMA Responses to the Public Citizen Report, Rx R&D Myths: The Case Against The Drug Industry s R&D Scare Card

(7/23/01) Rx R&D Myths: The Case Against the Drug Industry's R&D "Scare Card"

(4/11/01) Drug Industry Most Profitable Again

(10/6/00) Consumer Group Releases Detailed Analysis of Prescription Drug Industry Profitability as Debate Over Prescription Drug Issue Heats Up in Election

(10/6/00) Analysis of Corporate Profits, 1999

(1/26/00) Merrill Lynch Finds the Prescription Drug Fairness for Seniors Act Would Cut Drug Company Revenues by Only 3.3%

  • Campaign Contributions and Lobbying

(6/23/2004) The Medicare Drug War: Drug Companies and HMOs Led an Army of Nearly 1,000 Lobbyists to Promote Misguided Legislation and Increase Profits

(6/23/2003) The Other Drug War 2003: Drug Companies Deploy an Army of 675 Lobbyists to Protect Profits

(11/7/02) Public Citizen's Post-Election Analysis: Handful of Senate Moderates Now Hold Key to Protecting Consumer Interests

(10/21/02) United Seniors Association: Hired Guns for PhRMA and Other Corporate Interests -- Updated October 17, 2002

(10/21/02) Seniors Group Continues to Do Bidding of Drug Industry, Sponsor "Issue Ads" to Help Industry Allies in Campaigns

(10/14/02) Who's Pulling the Strings in Washington? How Drug Industry Profits "Buy" Special Access to Congress

(8/12/02) Public Citizen Urges FEC to Investigate United Seniors Association (USA)

(8/9/02) Letter to the FEC Concerning United Seniors Association Issue Ads

(7/19/02) Brand-Name Drug Companies Versus Generics: Lobbying and Campaign Contributions

(7/19/02) Brand-Name Drug Industry Overwhelms Generic in Campaign Contributions and Lobbying Spending

(7/16/02) New Report Unmasks United Seniors Association as Hired Gun for Drug Industry

(7/12/02) United Seniors Association: Hired Guns for PhRMA and Other Corporate Interests

(6/26/02) The Other Drug War II: Drug Companies Use an Army of 623 Lobbyists to Keep Profits Up (Fact Sheet)

(6/13/02) Biggest Drug Companies Expand Lobbying Army in 2001

(6/12/02) The Other Drug War II: Drug Companies Use an Army of 623 Lobbyists to Keep Profits Up (Report)

(11/4/01) New York Times Coverage of Public Citizen's "The Other Drug War..." Report

(7/23/01) The Other Drug War: Big Pharma's 625 Washington Lobbyists

(11/1/00) Rx Industry Goes for KO: Drug Companies Spend Record Amount This Election Cycle

(9/21/00) Top Bush Health Adviser Stands To Gain Personally from Candidate's Medicare Plan

(7/6/00) Addicting Congress: Drug Companies' Campaign Cash & Lobbying Expenses

(7/20/00) Citizens for Better Medicare: The Truth Behind the Drug Industry's Deception of America's Seniors Designed to Mislead America s Seniors

(4/5/00) New Investigative Study Reveals How Unhealthy Alliance Between HMOs and Congressional Leaders Threatens Patients' Rights Bill

(1/26/00) PhRMA s Secret Playbook: "Insider" Documents Show Prescription Drug Industry Continues Campaign to Undermine Support for a Prescription Drug Benefit

(1/4/00) How the Prescription Drug Industry "Buys" Special Influence in Washington

(6/25/99) Pharmaceutical Industry's Propaganda Campaign Against the Prescription Drug Fairness for Seniors Act

(3/9/99) Deborah Steelman Collected Nearly $3 Million from Health Industry Interests with Major Stake in Medicare Reform

 

Copyright © 2014 Public Citizen. Some rights reserved. Non-commercial use of text and images in which Public Citizen holds the copyright is permitted, with attribution, under the terms and conditions of a Creative Commons License. This Web site is shared by Public Citizen Inc. and Public Citizen Foundation. Learn More about the distinction between these two components of Public Citizen.


Public Citizen, Inc. and Public Citizen Foundation

 

Together, two separate corporate entities called Public Citizen, Inc. and Public Citizen Foundation, Inc., form Public Citizen. Both entities are part of the same overall organization, and this Web site refers to the two organizations collectively as Public Citizen.

Although the work of the two components overlaps, some activities are done by one component and not the other. The primary distinction is with respect to lobbying activity. Public Citizen, Inc., an IRS § 501(c)(4) entity, lobbies Congress to advance Public Citizen’s mission of protecting public health and safety, advancing government transparency, and urging corporate accountability. Public Citizen Foundation, however, is an IRS § 501(c)(3) organization. Accordingly, its ability to engage in lobbying is limited by federal law, but it may receive donations that are tax-deductible by the contributor. Public Citizen Inc. does most of the lobbying activity discussed on the Public Citizen Web site. Public Citizen Foundation performs most of the litigation and education activities discussed on the Web site.

You may make a contribution to Public Citizen, Inc., Public Citizen Foundation, or both. Contributions to both organizations are used to support our public interest work. However, each Public Citizen component will use only the funds contributed directly to it to carry out the activities it conducts as part of Public Citizen’s mission. Only gifts to the Foundation are tax-deductible. Individuals who want to join Public Citizen should make a contribution to Public Citizen, Inc., which will not be tax deductible.

 

To become a member of Public Citizen, click here.
To become a member and make an additional tax-deductible donation to Public Citizen Foundation, click here.